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Bioisosteres of 2PGH
Possible New Leads for TIM inhibitors
INTRODUCTION
IntroductionIn the previous chapter the strategy of rational inhibitor design was out-lined. Specific inhibitors for trypanosomal TIM based on structural dif-
ferences should eventually be obtained by extending known inhibitors in
order to reach out of the active site towards the so-called selectivity area
at residues 100-102. The potential inhibitors described in this chapter are
meant as a first step towards the design of these new, specific inhibitors. 
The new compounds were modelled in the X-ray structure of the com-
plex of trypanosomal TIM with G3P to check whether they would fit in
the active site and which points of interactions were present. The com-
pounds were subsequently synthesized and their affinities for both rabbit
muscle and trypanosomal TIM were measured. If a compound showed
affinity, it was soaked into crystals of the trypanosomal enzyme and an
X-ray structure of the complex of the compound and the enzyme was de-
termined. X-ray studies on complexes of two different inhibitors de-
scribed in this chapter with trypanosomal TIM are discussed in Appendix
1 (page 155) and Appendix 2 (page 160).
METHODS AND  RESULTS Methods and Results
Drug DesignSince 2PGH is the best competitive inhibitor of rabbit muscle TIM de-scribed so far, this compound was taken as a lead for the design of
new compounds. A well known method to make an bioisosteric replace-
ment in a phosphate containing compound is replacing the phosphate
moiety with a phosphonate group.1 Phosphonic acids are more stable in
aqueous solution, which may be an advantage in the testing of these com-
pounds under physiological conditions. Moreover, in this way, a possibil-
ity is created to branch the inhibitor from the carbon atom next to the
phosphonate group (henceforth called the C1 position) in order to reach
the selectivity area (see figure 2.8).
The replacement of the phosphate function by a phosphonate group pro-
vided the first bioisostere of 2PGH i . e .  N -hydroxy-3-phosphono-
propanamide (3PPH, compound 16, figure 3.1).
From the X-ray structure of the native enzyme and of complexes of try-
panosomal TIM with various inhibitors2,3 it was noticed that there might
not be enough space available for a branching of the aliphatic chain of
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3PPH at the C1-position. Therefore, a second variant of 2PGH was made,
in which the distance between the phosphate group and the hydroxamic
acid function was increased by one methylene group, leading to N -hy-
droxy-4-phosphonobutanamide (4PBH, compound 22). A longer chain
might push the phosphonic acid function out of the active site because of
the limited space available and consequently the enzyme would not pre-
sent steric interference with the extended aliphatic chain emanating from
the C1 position of the inhibitor. 
Another class of bioisosteres of 2PGH contained the isomers of the afore-
mentioned hydroxamic acids that were obtained by replacing the hydrox-
amic acid function with a N -hydroxy-N -formyl-amino group. These hy-
droxamic acids will be further referred to as i s o - hydroxamic acids (figure
3.1). The replacement yielded 2-(N -formyl-N -hydroxyamino)-ethylphos-
phonic acid (i s o -3PPH, compound 6) and 3-(N -formyl-N -hydroxyamino)-
propylphosphonic acid (i s o - 4PBH, compound 11). These compounds
have been isolated from a S t r e p t o m y c e s  r u b e l l o m u r i u s culture11,12 and
they have been proven to be active as antibiotics against Gram-negative
bacteria.13 The structure determination and synthesis of these antibiotics
has been described by Hemmi e t  a l . 14,15
The idea behind these i s o -hydroxamates as potential inhibitors for TIM is
that they resemble not only the transition state but also DGAP, the prod-
uct of the TIM reaction. According to the energy diagram developed by
Albery and Knowles,16 the dissociation of DGAP from TIM after the re-
action is the kinetic rate determining step of the reaction. It is therefore
conceivable that transition-state analogues that also resemble DGAP
might have a higher affinity for TIM than transition state analogues with
‘‘normal’’ hydroxamic acid functions that also resemble the substrate
DHAP.
Molecular Modelling
of 3PPH and iso-3PPH A priori modelling of the binding modes of 3PPH and i s o -3PPH wascarried out using the software package BIOGRAF 2.10.6 The pro-
tein structure used was that observed in the complex between trypanoso-
mal TIM and glycerol-3-phosphate (G3P) with all water molecules de-
leted.2 Only a static shell of protein atoms within 9Å from any atom of
the G3P-ligand was included in the calculations. Standard united-atom
types from the Dreiding-I force field7 were assigned to the atoms of both
the protein and the ligand; heteroatoms were supplemented where neces-
sary with hydrogen atoms which are used in an explicitly geometrical hy-
drogen bond potential term. All energy calculations were carried out "i n
v a c u o " without the electrostatic term of the potential energy function. A
long range cut-off distance of 9Å was chosen for the non-bonded interac-
tions.
For generating 3PPH the atomic force field types of G3P in the experi-
mentally determined complex were edited appropriately where required.
Figure 3.1
The four newly designed inhibi-
tors for TIM, conceptually re-
lated to the transition state ana-
logue 2PGH (X denotes a bioi-
sosteric replacement site).
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This straightforward ligand mutation was based on the assumption that
the hydrogen bond interactions between the alcohol functions of G3P and
the catalytic residues Lys313 and His395 would be retained in the 3PPH
complex.
In addition, a torsional restraint was imposed upon the hydroxamic acid
functions, enforcing a c i s -planar arrangement; a force-constant of 20
kcal/mol was used in the cosine expansion potential. This c i s -planarity
was established from the search for hydroxamic acid compounds in the
Cambridge Structural database.8 The preference for this conformation has
also been observed in solution.9 The necessity of the torsional restraint
was imposed by the failure of the Dreiding-I force field to reproduce the
planarity of the hydroxamic acid function. Following the arguments of
Collins,4 binding of the unionized hydroxamic acid function was as-
sumed.
Subsequently, the 3PPH model was submitted to a conjugate gradient en-
ergy minimization in the protein environment. During this operation, the
phosphorus atom was fixed as the structures of previously determined
complexes of trypanosomal TIM with phosphate and phosphonates had
shown the phosphorus atoms superimposing within 0.1Å from each
other. The criterion of convergence, the rms gradient, was set to 0.1
kcal/mol.Å.
In a similar way i s o -3PPH was modelled in the protein environment, but
here the modelled 3PPH was taken as a starting point. Also here the pref-
erence for c i s -planarity was inferred from small molecule crystal struc-
tures.10 A c i s-planar arrangement was imposed upon the "i s o -hydroxamic
acid" function by a torsional restraint of 20 kcal/mol. The energy minimi-
zation smoothly converged.
From the modelling of 3PPH and i s o -3PPH, the hydroxamate group and
the i s o - hydroxamate group appeared to be hydrogen bonded directly to
the side chains of the catalytic residues Lys313, His395, Glu467 and
Asn311.
The validity of this model was confirmed by the experimental X-ray
structure determination of the complex of trypanosomal TIM and i s o -
3PPH (see Appendix 1).3 The predicted active site interactions of 3PPH
are shown in figure 3.3. The observed active site interactions of i s o - 3PPH
are depicted in figure 3.4. 
The modelling of i s o - 3PPH was quite successful (see table I), giving a
rms error of 0.63Å for the 10 non hydrogen atoms of the ligand. The oxy-
gen atoms 4 and 5 of 3PPH and i s o - 3PPH in the modelled structure of
their respective complexes with trypanosomal TIM are in almost the
same position as the corresponding oxygens in the X-ray structure of the
G3P-TIM complex which was the starting point for the modelling. The
distances between the positions of O5 and O6 in the G3P structure and G3P numbering scheme
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their counterparts in the modelled structures are, for the 3PPH-complex
0.6Å and 0.5Å and for the i s o - 3PPH-complex 0.5Å and 0.8Å, respec-
tively. A comparison of the observed structure of the complex of i s o -
3PPH with T .  b r u c e i  TIM and the observed structure of G3P with T .
b r u c e i  TIM is discussed in Appendix 1 (page 157) The rms difference in
the positions of all corresponding atoms of 3PPH and i s o -3PPH was
0.38Å indicating an almost exact superposition of both ligands (figure
3.2).
In the modelled 3PPH structure the distance between Ne2(His-395) and
O4 and O5 of 3PPH is 2.8Å and 3.1Å, respectively. In the X-ray structure
of yeast TIM with 2-PGH5 these distances are 2.7Å to O4 and 3.1Å to O5.
This is an indication that the model of the complex of 3PPH with T .
b r u c e i  TIM is valid. 
















Errors in the modelling and
atomic solvent accessibility of
iso-3PPH observed in the X-
ray structure of the complex of
the ligand with T.brucei TIM.
Figure 3.2
Stereoview of the superposition
of the modelled structures of
3PPH and iso-3PPH. The hyd-
roxamic acid oxygens virtually
coincide.
Figure 3.3
Stereoview of the modelled
structure of the complex of
3PPH with trypanosomal TIM.
The protein model was taken
from the crystallographically ob-
served structure of the complex
with G3P.2 Hydrogen bonds
are indicated by dashed lines. 
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In the model of the complex of 3PPH with TIM the N-hydroxyl group in-
teracts with Oe2 of Glu467, in the i s o -3PPH however it interacts with Oe1
(figure 3.4). The difference in the position of the N-hydroxyamido group
in 3PPH and i s o -3PPH is probably the cause of this difference in interac-
tion with residue Glu467.
In table I, also the atomic solvent accessibilities of the ligand in its com-
plexed environment, are given. These have been calculated to give a
guide to which atoms of the ligand are surrounded by space suitable for
the addition of extending groups. To produce these figures, a probe size
of 1.4Å has been used to search around the van der Waals radii of the li-
gand atoms. The most interesting result is the slight solvent accessibility
of the C1 atom of i s o - 3PPH. The solvent accessibility of previously stud-
ied ligands in TIM with a closed loop had shown no solvent accessibility
of any atom in an equivalent position to C1 of i s o - 3PPH.
3 Apart from this
atom, no atoms of the ligand studied here are in sufficient space to allow
addition of further groups without assuming protein flexibility.
SynthesisThe i s o - hydroxamic acid i s o - 3PPH was prepared according to SchemeI as was described by Hemmi e t  a l . 14,15 Benzyloxyamine 1 was pre-
pared from hydroxyurethane and benzyl bromide followed by the hydro-
lysis of the product, as described by Fuller and King.17 Subsequently, 1
was treated with para-toluenesulfonyl chloride in pyridine. The resulting
N -benzyloxy-p a r a -tolylsulphonamide 2 was purified by recrystallisation
from toluene and petroleum ether. Subsequently, 2 was N -alkylated with
1,2-dibromoethane. This provided the (N -benzyloxy-N -Tosyl)-2-bromo-
ethylamine 3, which was treated with triethyl phosphite in a Michaelis-
Arbuzov reaction19 in which the bromine atom was replaced by a diethyl
Figure 3.4
Stereoview of the crystal-
lographically observed structure
of the complex of iso-3PPH with
trypanosomal TIM. Hydrogen
bonds are indicated by dashed
lines.
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phosphonic acid function to provide 4. After chromatographic purifica-
tion, all protecting groups were removed by refluxing 4 for two days in a
mixture of glacial acetic acid and concentrated hydrochloric acid. The re-
sulting (N-hydroxyamine)-2-ethylphosphonic acid 5 was then formylated
with the mixed anhydride of formic acid and acetic acid. The i s o - hydrox-
amic acid 6 was crystallised as potassium salt.
The deprotection of the intermediate 4 took 48 hours of boiling in glacial
acetic acid and concentrated hydrochloric acid. The bottle neck in this de-
protection step seemed the hydrolysis of the sulphonamide function.
Therefore the alternative route depicted in scheme II was investigated for
the synthesis of i s o -4PBH. In this route the prolonged hydrolysis of the
sulphonamide of 4 was circumvented. Hence, benzyloxyamine was first
protected with a t-butoxycarbonyl (t-Boc) group and then product 8 was
N-alkylated with diethyl 3-bromopropylphosphonate 7 at low tempera-
ture to provide 9. 
The deprotection was accomplished by refluxing 9 in concentrated hydro-
chloric acid overnight. During this procedure the t-Boc group was re-
moved in a matter of minutes after the addition of concentrated hydro-
chloric acid and hence the difficult removal of the tosyl-group in com-
pound 4 was successfully circumvented. 
The resulting N -hydroxyaminopropyl phosphonic acid 10 was formylated
with formic-acetic anhydride in the same manner as in the previously de-
scribed route. The product 11, i . e .  i s o -4PBH, was precipitated as mono-
sodium salt.
Scheme I
a: pyridine, 25°C; b: NaOEt/
EtOH, 78°C 8 hr. 53%;
c: P(OEt)3,160°C 10 hr.,
90%; d: hydrochloric acid
36%/glacial acetic acid,
100°C 50hr., approx. 40%; 
e: HCOOH/Ac2O, 25°C 2 hr.,
65% crystallised as potas-
sium salt from MeOH/EtOH.
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Collins4 prepared 2PGH according to the following method (Scheme III):
first he esterified 2PG with ethanol and converted the resulting ethyl ester
in a hydroxamic acid (2PGH) by treating it with hydroxylamine at pH
11.7 in the presence of lithium hydroxide. The resulting product con-
tained about 90% dilithium 2PGH and 10% trilithium 2PG. Converting
this mixture to the b i s -cyclohexylammonium salt by passing the mixture
through an ion-exchange column in the cyclohexylammonium form and
crystallising the resulting product from water/acetone provided a pure
product. In attempts pursued to synthesize 3PPH according to this
method starting from 3PP, it proved very difficult to remove the carbox-
ylic acid (i . e .  the starting material 3PP). This method was therefore aban-
doned and 3PPH and 4PBH were prepared according to the method as
shown in Scheme IV.
The first two steps of the synthesis have been described by Dixon and
Sparkes.21 Acrylic acid was treated with triethyl phosphite in a Michael-
addition-like reaction to yield 3-(diethoxyphosphinoyl)propionic acid
(12). This was converted to 13 with oxalyl chloride at low temperature to
prevent decomposition of the product (see Intermezzo I). Then 13 was

























Collins’ method for the conver-
sion of 2PG into 2PGH. a: etha-
nol HCl; b: HONH2.HCl, LiOH
in water; 15 min; c: conversion
to the bis-cyclohexylammoni-




a: 160°C, 11/2 hr.; b: Dioxan/
water, 20°C 1hr.98%; c: NaH in
DMF, -20°C - +18°C 18hr. 60%;
d: hydrochloric acid 36%, 100°C
18hr 55%; e: HCOOH/ Ac2O,
25°C 1hr., 65%, crystallised as
mono sodium salt.
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form the protected hydroxamic acid 14. It proved useful to deprotect the
phosphonic acid function first according to the method of McKenna20
with trimethyl bromosilane and subsequently alcoholyse the intermediate
(trimethylsilyloxy)phosphonic acid ester to provide 15. This was immedi-
ately converted to its b i s -cyclohexylammonium salt because the phos-
phonic acid group catalysed the methanolysis of the protected hydrox-
amic acid moiety.* Finally, the hydroxamic acid function was depro-
tected by hydrogenolysis. This yielded 3PPH (16) which was also
crystallised as b i s -cyclohexylammonium salt.
4PBH was prepared in the same manner. The commercially available
ethyl 3-bromobutanoate was treated in a Michaelis-Arbuzov reaction with
triethyl phosphite to provide ethyl diethyl-4-phosphonobutanoate 17. The
carboxylic ester moiety of 17 was hydrolysed to provide diethyl-4-phos-
Scheme IV: Synthesis of 3PPH and 4PBH
a: 100°C, 5 hr.;a’: 160°C, 18 hrs; b: Hydrolysis: NaOH/water/ ethanol;c: oxalyl chloride, 0°C; 2
hr.; d: benzyloxyamine; e: NEt3/CHCl3, 0°C, 3 hr.; f: 3 equivalents TMSBr; g: alcoholysis with
MeOH, crystallisation as cyclohexylammonium salt from water/acetone; h: H2 10% Pd/C; crys-
tallisation as cyclohexylammonium salt from water/ acetone.
The acyl chlorides 13 and
19 are very unstable. When
the temperature is slightly
elevated, (>40°C) an intra-
molecular ringclosure takes
place and a mixed internal
anhydride is formed that is
unreactive in the following
steps. Therefore, the tempe-
ratures in the reaction steps
in which the acyl chlorides
were involved, were kept be-
low 0°C to avoid this unwan-
ted side reaction. After a few
hours of stirring with cooling
the temperature was allo-




X-Ray structure of compound 21.
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* methanol was used in the alcoholysis of the b i s -(trimethylsilyl) ester of the phosphonate
15 and as solvent in the hydrogenolysis of the O-benzyl hydroxamic acid group.
phonobutyric acid (18). Then the same procedure as described above was
used to convert 18 into 4PBH (22), which was crystallised as b i s-cyclo-
hexylammonium salt.
Pharmacological
StudiesThe inhibition of TIM by the new inhibitors was investigated with en-zymes of two sources: T r y p a n o s o m a  b r u c e i  isolated and purified to a
homogeneous state as described previously,25 and rabbit muscle which is
commercially available.
The reaction mixture contained variable concentrations of the different
inhibitors and about 10 ng of TIM in a 0.1 M triethanolamine buffer of
pH 7.6. The reaction was started after five minutes preincubation by the
addition of 0.28mM NADH, 20mg glycerol 3-phosphate dehydrogenase
and variable concentrations of glyceraldehyde 3-phosphate between 0.06
and 0.3 mM. The initial rate was calculated from the change in NADH
absorbance at 340 nm. All experiments were performed at 25°C.26
The inhibition constants were obtained as the slopes of a Hanes-Woolf
plot. The type of inhibition was measured by the characteristics of the
Hanes-Woolf plots at different inhibitor concentrations.
IC50 values were determined from plots of the initial reaction rate in the
presence of the inhibitor as the percentage of the rate under identical con-
ditions in the absence of inhibitor, versus the concentration of the inhibi-
tor. The results are presented in Table II. 
I s o - 3PPH and 4PBH behaved as competitive inhibitors of both the T .
b r u c e i  and the rabbit muscle (RM) TIM, when DGAP was used as a sub-
strate. TIM from rabbit muscle is less sensitive to i s o - 3PPH. It inhibits
the enzyme non-competitively. Contrary to i s o - 3PPH, 3PPH is more ef-
fective on RM TIM than on T .  b r u c e i  TIM and it inhibits RM TIM in a
competitive way with respect to DGAP. T .  b r u c e i  TIM, however, is in-
hibited by 3PPH in a non-competitive manner. Of all four inhibitors
tested, i s o - 4PBH is the least potent inhibitor of both TIMs.
Trypanosoma brucei TIM Rabbit muscle TIM
Compound IC50 (mM) Ki (mM) IC50  (mM) Ki (mM)
2PGH 0.004
3PPH 1.5 1.4 1.2 0.4
i s o -3PPH 0.5 0.5 0.5 1.5
4PBH 0.4 0.3 0.4 0.3
i s o -4PBH 6.7 3.7 9.5 8.9
Table II
IC50 values and inhibition con-
stants of 3PPH, iso-3PPH,
4PBH and iso-4PBH for trypa-
nosomal and rabbit muscle TIM.
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The qualitative nature of the protein ligand interactions in the ob-served structure of the i s o - 3PPH complex with TIM, agrees well
with the assumptions used in the modelling of the compounds prior to the
structure determination. This is encouraging because it demonstrates that
it is possible to expand upon the knowledge obtained from previously de-
termined structures i . e .  the validity of the rational drug design cycle is
confirmed here.30 
Given a r.m.s. error of 0.63Å for the 10 non hydrogen atoms of i s o -
3PPH, the modelling of the ligand can be considered quite successful. It
has to be stated that the succes in the prediction of the binding mode of
the ligands studied here is also due to several particular conditions in this
analysis; e . g .  we predicted the binding mode of 3PPH and i s o - 3PPH start-
ing from a ligand with a large similarity in structure, of which the com-
plexed structure was already known, i . e .  G3P. We had a firmly estab-
lished starting point being: the principle determinant of ligand binding to
TIM is the well defined interaction of main chain nitrogens with the
phosphate group. Finally the binding site of the ligands is almost entirely
sealed off from the solvent, removing the complications of treatment of
the solvent in energy calculations.
A comparison of the X-ray structures of the complexes of 2PGH with T .
b r u c e i  TIM3 and of i s o -3PPH and T .  b r u c e i  TIM shows that the confor-
mation of i s o -3PPH is considerably different from the conformation of
2PGH. The difference lies in the torsion angle equivalent to C1-C2-N1-O5
in i s o -3PPH. In 2PGH and G3P the equivalent atoms are approximately
coplanar, whereas in i s o -3PPH they are staggered, defining a torsion an-
Figure 3.6
Stereoview of the conforma-
tions of iso-3PPH and 2PGH
when bound to T. brucei TIM.
The final model of iso-3PPH is
shown in white, along with the
disposition of the hydrogen bon-
ding side chains around the iso-
hydroxamic acid group.
For comparison, the conforma-
tion of 2PGH and Glu167 in the
trypanosomal TIM-2PGH com-
plex is shown in black.
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* The discussion on the comparison of the X-ray structures of the i s o -3PPH T .  b r u c e i  TIM
complex and the 2PGH T .  b r u c e i  TIM complex was taken from the thesis of M.E.M.
Noble.3
gle of 58°. The eclipsed conformation observed in the 2PGH and G3P
complexes with T .  b r u c e i  TIM is consistent with the stereoelectronic
preference of this conformation if the reaction of TIM is to proceed to the
desired product (DGAP), rather than to methylglyoxal and phosphate.
The difference in bound conformation for i s o -3PPH must be related to
the phosphonate group. The major consequence of the transition from a
phosphate to a phosphonate group is:
1 - the price of the steric clash between the methylene group (C1), and
the oxygen (O5) is likely to be higher than for the equivalent clash in
the phosphate containing compounds, due to the larger radius of a
methylene group compared to an oxygen. (compare figure 2.6, page
28).
2 - the P-C bond is longer than the P-O bond in a phosphate (1.81Å vs.
1.62Å). Because the positions of atoms at either end of the molecules
are fixed by hydrogen bonds, the presence of a longer P-C bond must
be accomodated by having a less extended conformation. 
Correlated with the difference in the torsion angle described above is a
difference in the position and orientation of the i s o -hydroxamic acid
function of i s o -3PPH compared to the "normal" hydroxamic acid group
of 2PGH. This difference is not reflected in the protein hydrogen bonds,
which are similar to those observed for 2PGH, however, a subtle differ-
ence in the position of the catalytic base is observed. The Glu167 side
chain is more "swung in" in the i s o -3PPH TIM complex than in the
2PGH TIM complex. This results in a different hydrogen bond of this
side chain with the ligand; in the i s o -3PPH complex it is with O5,
whereas in the 2PGH complex it is with O6 of the ligand. This difference
in interaction reflects the different natures of O5 and O6 in the two li-
gands; in i s o -3PPH, O5 is a hydroxyl oxygen and O6 is a carbonyl oxygen
and in 2PGH it is the other way round.
It is tempting to speculate that the difference between the position of
Glu167 in the i s o -3PPH complex, and its position in the 2PGH complex
is a direct result of the chemical difference between the two hydroxamic
acid function in the two ligands. If so, this minor difference may reflect
the movement of the glutamate between its conformation interacting with
the ene-diolate intermediate (resembled by 2PGH) and its conformation
when interacting with DGAP (resembled by i s o -3PPH).
The binding mode of 4PBH, as revealed by the X-ray structure determi-
nation31 of the complex of this inhibitor with T .  b r u c e i  TIM, shows that
the concept that a longer alkyl chain between the phosphonate group and
the hydroxamic acid function pushes the phosphonate group to the out-
side of the active site is indeed valid. The alkyl chain is conceptually one
methylene unit longer than the lead compound and the phosphonate moi-
ety of 4PBH is located some 1.5Å further to the outside of the active site
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compared to the phosphate position in the structure of the complex of
2PGH with yeast TIM. The hydroxamic acid function of 4PBH is located
in roughly the same position as in that of the lead compound and has
similar interactions with Lys13 and His95. The active site base Glu167 is
in a "swung out" conformation in contrast to its "swung in" conformation
in the 2PGH-complex. This "swung out" conformation results in an ab-
sence of interactions with the ligand.
The X-ray structure of the 4PBH-complex with T .  b r u c e i  TIM also re-
vealed the absence of strain in the alkyl chain observed in 2PGH and G3P
when bound to T .  b r u c e i  TIM2 which are forced in an eclipsed conforma-
tion by the enzyme (v i d e  s u p r a ).
For the rational design of specific inhibitors of trypanosomal TIM, this
study has produced an interesting observation, namely that the C1 atom of
i s o - 3PPH has been shown to have a solvent accessibility of 0.6 Å2 and is
surrounded by space in such a way as to allow branching. Analysis of this
space compared to the van der Waals surface of the enzyme suggests that
it lies in a suitable direction for branching away from the active site. Fur-
ther analysis reveals that a branch leading from C1 would necessarily dis-
place a water molecule which has been found in the X-ray structures of
all five trypanosomal TIM-inhibitor complexes solved so far.2 This water
molecule forms interactions with the ligand phosphate and with the
Lys313 of the enzyme, suggesting that, if it is to be lost, then some other
hydrogen bond donor or acceptor has to replace it.
In conjunction with this is the observation in the X-ray structure of the
4PBH-complex that the flexible loop is in an open conformation leaving
a considerable part of the inhibitor exposed. The carbon atom connected
to the phosphonate group has an accessibility of 8.0Å2. 
In Vitro Activities The inhibition constants of the inhibitors for trypanosomal TIM andthe rabbit muscle TIM are virtually the same. Since the inhibitors de-
scribed in this chapter are directed solely against the active site, and be-
cause of the fact that the primary and secondary structure of the active
site is conserved in all species, this is not too surprising. However, replac-
ing the phosphate moiety in 2PGH by a phosphonate group in 3PPH, i . e .
an oxygen atom with an methylene group, resulted in a dramatic loss of
affinity; it dropped by a factor as high as 375 in the case of T .  b r u c e i  TIM
and 300 in the case of rabbit mucle TIM. For i s o - 3PPH the loss of affin-
ity, compared to the affinity of 2PGH, is less but still a factor of 100. This
dramatic loss of affinity was also noticed when the inhibition constant of
2PG and 3PP was compared. Here the loss was a factor of 4500. Dixon
and Sparkes21reported a loss in affinity of a factor 1000.
When the relative affinities of the compounds described in this chapter
are compared some inconsistencies are observed (figure 3.7). First, based
on the structural similarities between DHAP and the "normal" hydrox-
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amic acids 3PPH and 4PBH and between DGAP and the i s o -hydroxamic
acids i s o -3PPH and i s o -4PBH, it was speculated that the affinity would
rise when the hydroxamate function would be replaced with an i s o -hy-
droxamate group. The affinity of DGAP for T .  b r u c e i  TIM is 83 fold
higher than the affinity of DHAP, whereas in the case of rabbit muscle
TIM DGAP has a 26 fold higher affinity than DHAP. When the 3PPH
compounds are compared it is observed that the transition from hydrox-
amate to i s o -hydroxamate results in a rise of affinity by a factor of 3, so
the concept seems to be valid though the effect it is not as pronounced as
in the case of the natural substrates.
In the case of the longer 4PBH compounds, the transition from "normal"
hydroxamic acid to i s o -hydroxamic acid results in a dramatic drop in the
affinity with a factor as high as 17 for T .  b r u c e i TIM and 24 for rabbit
muscle TIM. This is inconsistent with the picture described above. In the
X-ray structure of 4PBH with T .  b r u c e i  TIM, Verlinde e t  a l .31 observed
that the active site base is in a "swung out" conformation and does not
participate in the binding of the ligand. By analogy it is conceivable that
in the complex of i s o -4PBH with TIM, the active site base is in the same
conformation. The environment of the hydroxamic acid function in the
complexes of 4PBH and i s o -4PBH with TIM is therefore different from
that in the complexes of 3PPH and i s o -3PPH with TIM. It is not incon-
ceivable that the active site with the Glu167 in the "swung out" confor-
mation has more difficulty in accomodating the i s o -hydroxamic acid
function than the normal hydroxamic acid group resulting in a lower af-
finity for i s o -4PBH compared to 4PBH.
Another aspect of this study is the chain lengthening of the compounds
meant to push the phosphonate moiety out of the active site. That this in-
deed happens is confirmed by the X-ray structure of the complex of
4PBH with T .  b r u c e i  TIM. When the relative affinities of i s o -3PPH and
i s o -4PBH and of 3PPH and 4PBH are compared, it is observed that in the
i s o -3PPH
Chain
lengthening
i s o -4PBH 4PBH
T. brucei TIM: IC = 0.5 mM
Rabbit muscle TIM: IC = 0.5 mM
50
50
T. brucei TIM: IC = 6.7 mM
Rabbit muscle TIM: IC = 9.5 mM
50
50
T. brucei TIM: IC = 0.4 mM




T. brucei TIM: IC = 1.5 mM










iso-Hydroxamic Acids Hydroxamic Acids Figure 3.7Schematic comparison of the
IC50 values of the inhibitors ob-
served for T. brucei TIM and
Rabbit muscle TIM.
B io i s o s t e r e s  o f  2 P G H
P o s s i b l e  N e w  l e a d s  f o r  T I M  I n h i b i t o r s
D i s c u s s i o n      59
case of the "normal" hydroxamates, a chain lengthening results in an in-
crease in affinity, whereas in the case of the i s o -hydroxamates a sharp de-
crease in affinity is observed. Verlinde e t  a l .  observed that the alkyl chain
of 4PBH is in a non-strained conformation in contrast to the eclipsed con-
formations of 2PGH and of 3PP observed in the complexes with yeast
TIM5 and with T .  b r u c e i TIM.2,3 The increase in affinity observed with
the "normal" hydroxamates can be explained by the absence of strain in
the longer alkyl chain as mentioned above.
It is conceivable that also i s o -4PBH binds in such a non-strained confor-
mation. The observed decrease in affinity when lengthening the distance
between the phosphonate moiety and the i s o -hydroxamic acid group can
therefore only be explained by the assumption that the conformational
change of the active site base results in a lower affinity of the active site
for i s o -hydroxamates. Since the affinities of i s o -3PPH and 4PBH are vir-
tually the same, it is tempting to calculate a factor of about 20 by which
the affinity of the active site for i s o -hydroxamates drops due to the con-
formational change of Glu167 (Glu467 in the second subunit).
In summary, this study has confirmed that the transition of phosphates to
phosphonates results in a dramatic loss of affinity. Compared to 3PP, re-
placing the carboxylic acid group by a hydroxamic acid function, the af-
finity was raised by a factor of 27 and the affinity of 3PPH is comparable
to that of the natural substrate DHAP.26 The active site base can adopt
two distinct conformations in which also different affinities for i s o -hy-
droxamic acids can be observed. The difference in affinity for "normal"
hydroxamic acids is less pronounced. Chain lengthening indeed results in
a new position of the phosphonate moiety more to the outside of the ac-
tive site and in conjunction with this, the flexible loop stays in an open
conformation. It seems, therefore, advantageous when the future inhibi-
tors will be able to keep the flexible loop in an open conformation in or-
der to leave space for extensions towards the selectivity area.
EXPERIMENTAL  SECTION Experimental section
Synthesis All reagents were purchased from Al -drich Chemical Company and Jans -
sen Chimica and were used as received.
Solvents were reagent grade and were
used without further purification unless
indicated otherwise. DMF was dried by
distillation from molsieves 3Å. 
IR, NMR and MS data were determined
for all compounds and were evaluated as
consistent with the indicated structures.
These data are presented only where re -
quired for structural assignment. 
Infrared Spectra were taken on a Beck -
man AccuLab 2 and on a Mattson Gene -
sis FTIR spectrometer. Only the
important characteristic absorptions are
given.
The chemical ionisation (CI) mass spec -
tra were obtained on a Finnigan 3300
system and an Unicam Automass 150.
The electrospray ionisation spectra 32,33
were taken with a Nermag R 3010 mass
spectrometer equipped with a home built
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ionspray source. Only the molecular
masses are given.
60 MHz 1H-NMR-spectra were taken on
a Hitachi Perkin-Elmer R24 B spec -
trometer. Chemical shifts are denoted
relative to tetramethylsilane (TMS) as in -
ternal standard. The hydrogen and carbon
atoms to which the signals apply are de -
noted in a bold typeface. Splitting pat -
terns are designated s, singlet; d, doublet;
t, triplet, q, quartet; m, multiplet; b,
broad.
200 MHz 1H-NMR-spectra, 13C-NMR
spectra and 31P-NMR spectra were re -
corded on a Varian Gemini 200 NMR
system. 
Benzyloxyamine hydrochloride (1) 
1 was prepared according to the method
of Fuller and King. 17
O-benzyl-N-tosylhydroxylamine (2)
2 was prepared according to the method
of Isowa e t  a l .18 The product was puri -
fied by recrystallisation from tolu -
ene/light petroleum (bpt.: 40°-60°C).
Yield = 87%. Mp 95°C (Lit: 18 93-97°C);
1H NMR (60 MHz, CDCl 3): d 2.4 (s, 3H,
ArCH3), 4.95 (s, 2H, OCH2Ar), 7.15-
7.45 (m, 7H, Ar), 7.8 (d, 2H, J = 9 Hz,
Ar); IR (KBr, cm -1): 3260 (NH), 1600
(Ar), 1330 (O=S=O), 1165 (O=S=O).
(N-Tosyl-N-benzyloxy)-2-bromoethyla-
mine (3)
13.0 g (47 mmol) of 2 was converted
with 17.78 (95 mmol) of 1,2-dibro -
moethane and 1.0 (47 mmol) of sodium
according to the method of Hemmi e t
a l . 15,18 Yield = 14.3 g (79%). Mp: 120.3-
121°C (Lit:15 120-122°C); 1H NMR was
identical with previous data. 15 IR (NaCl
plates): 3080 cm -1, 3050 (Ar), 3000-2900




Compound 4 was prepared by the Ar -
buzov reaction of 13.7 g (36 mmol) of 3
and 17.8 g (107 mmol) of triethyl
phosphite as described by Hemmi e t  a l . 15
The crude product was purified by col -
umn chromatograhy on silica, eluting
with ethylacetate. Attempts to crystallise
the compound as described by Hemmi e t
a l .15 failed. Also after prolonged stand -
ing, no crystallisation occured. Yield =
9.3 g (= 59%). 1H NMR data were con -
sistent with the previous reported spec -
tra.15 IR (NaCl plates, cm -1) 3080, 3050
(Ar), 3000-2880 (Aliph.), 1600 (Ar),




Compound 5 was prepared exactly ac -
cording to the method of Hemmi e t  a l . 15
Yield = 43%. 1H NMR data were the
same as those reported by the aforemen -
tioned authors. IR (KBr, cm -1) 3200-
2200 (Aliph, NH, OHs), 1028 (P-O).
(N-formyl-N-hydroxyamino)ethylphos -
phonic acid (6, iso-3PPH)
Compound 6 was prepared exactly ac -
cording to the method of Hemmi e t  a l . 15
1H NMR and IR spectral data were con -
sistent with those reported earlier. 15
Anal. Calcd for C 3H7KNO5P: C, 17.39;




This compound has been prepared before
by Kosolapoff.23 A mixture of 16.6 g
(0.1 mol) of triethylphosphite and 101 g
(0.5 mol) of trimethylene dibromide was
heated in a Claisen distillation apparatus.
When the temperature reached 150°C a
violent reaction started and ethyl bromide
distilled over (39°C). When the ethyl
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bromide production diminished the mix -
ture was heated for another hour. Then,
gradually, the pressure was diminished
and the excess of trimethylene dibromide
was distilled off. The remainder was re -
moved by rotary evaporation at 0.05
mmHg on a hot waterbath (75°C). The
residue (7) was used without further puri -
fication. Yield = 24.1 g (=93%): 1H
NMR and IR data were consistent with




8 was prepared according to the method
of Sulsky e t  a l . 29 Yield = 91%. 1H NMR
(60 MHz, CDCl3): d 1.4 (s, 9H,
C(CH3)3), 4.8 (s, 2H, OCH2), 7.35 (s,
5H, Ar), 8.05 (s, 1H, NH). IR (NaCl
plates), 3320 (NH), 3020, 3050, 3080
(Ar), 3000, 2950, 2890 (Aliph.), 1740





0.5 g (13 mmol) 60% sodiumhydride dis -
persion in oil was washed with light pe -
troleum (bp 40°- 60°C). in a nitrogen
atmosphere. A solution of 10 g (45
mmol) of 8 in 15 mL dried DMF was
added dropwise while maintaining the
temperature at ambient values. When the
effervescence had ceased the mixture
was cooled to -30°C. A solution of 11.6 g
(45 mmol) of 7 in 15 mL dried DMF was
added dropwise. After the addition was
complete, stirring was continued at -30°C
and then the temperature was allowed to
rise very slowly to room temperature
overnight. The reaction mixture was
poured into 300 mL of water and ex -
tracted three times with 150 mL of ethy -
lacetate. The combined organic layers
were washed with brine and dried over
MgSO4. After filtration and concentra -
tion 17 g of crude product was obtained.
This was purified by chromatography
over silicagel, eluting with ethylacetate.
In this way, 11.1 g (=62%) of 9 was ob-
tained. 1H NMR (200 MHz, CDCl 3) d
1.16 (t, 3H, J = 6 Hz, OCH 2CH3), 1.37
(s, 9H, C(CH3), 1.51-1.68 (m, 2H,
PCH2CH2), 1.70-1.85 (m, 2H,
PCH2CH2CH2), 3.34 (t, 2H, J = 4Hz,
CH2N), 3.85-4.06 (m, 4H, OC H2CH3),
4.70 (s, 2H, OCH2Ar), 7.18-7.30 (m, 5H,
C6H5); 
13C NMR (200MHz, CDCl 3) d
16.28 (OCH2CH3, J CP = 7 Hz), 20.01
(PCH2CH2, J CP = 4.6), 23.11 (PCH2,
J CP = 142 Hz), 27.96 (C( CH3)3), 49.49
(CH2N, J CP = 19 Hz), 61.3 (O CH2CH3,
J CP = 6.9 Hz), 76.82 (O CH2Ar), 81.27
(OC(CH3)3), 128.22, 128.31, 129.13 (Ar,
CH), 135.24 (Ar, C), 156.13 (C=O); 31P
NMR d 31.38; IR (NaCl plates): 3080,
3050 (Ar, CH), 2980, 2950, 2890 (Aliph,
CH), 1710(C=O), 1020 (P-O); MS (CI,
NH3) (M+1): 




9 was deprotected by the addition of con -
centrated hydrochloric acid. A violent re -
action occured upon the addition of the
hydrochloric acid and when the efferves -
cence had subsided the mixture was
boiled overnight. The workup procedure
was the same as the one used by Hemmi
e t  a l . 14,15 for the synthesis of i s o -3PPH
(6). Yield = 65%. Mp: 163-167°C (dec.)
(Lit:14 159-165°C dec.); IR (KBr, cm -1)
3300 (NH, OHs, Aliph. CH), 1130
(P=O), 1000 (P-O); 13C NMR (200
MHz, D2O), d 17.8 (PCH2CH2, J CP =
4.6 Hz), 25.0 (PCH2CH2, J CP = 134.7
Hz), 51.6 (CH2N, J CP = 17.3 Hz); MS
(electrospray, H2O/MeOH, neg. ions):
(M-1): m/e = 154, (2M-1): m/e = 309,
(3M-1): m/e = 464.
(N-formyl-N-hydroxyamino)propylp-
hosphonic acid (11, iso-4PBH)
11 was prepared from 10 according to the
method of Hemmi e t  a l . 14,15
S e c t i o n  I I  N e w  H y d r o x a m ic  A c id  c o n t a i n i n g  I n h i b i t o r s
62     E x p e r i m e n t a l  s e c t i o n
Mp: 181.9°-182.8°C (dec.) (Lit: 15 189-
191°C dec.); 1H NMR (200 MHz, D 2O)
d 1.4-1.6 (m, 2H), 1.75-1.93 (m, 2H),
3.55 (t, 2H, J  = 6 Hz), 7.91, (s) 8.27 (s,
total 1H); (13C NMR d 21.5 (CH2CH2,
J CP = 3 Hz), 24.9 (PCH2, J CP = 183 Hz)
51.8 (CH2N J CP = 16.7 Hz) 159.1
(C=O); 31P NMR d 27; MS (elec-
trospray, H2O/MeOH, neg. ions): (M-1):m/e = 182, (anion+Na-salt=182+205): m/e
= 387; Anal. calc. for C 4H9NNaO5P: C,




12 was prepared according to the method
of Dixon and Sparkes. 21 Yield = 70%.
1H NMR (60 MHz, CDCl 3) d 1.42 (t,
3H, J  = 7 Hz, CH3CH2O), 1.8-3.1 (m,
4H, CH2CH2), 4.2 (m, 4H, CH 3CH2O),
10.7 (s, 1H, COOH); IR (NaCl plates)
3600-2400 (COOH), 2980, 2940 (Aliph.
CH), 1730 (C=O), 1395, 1370 (Aliph.
CH), 1200 (P=O), 1020 (P-O); MS (EI):




13 was prepared from 12 according to
the method of Dixon and Sparkes 21 and
used without further purification. IR
(NaCl) 2980, 2940 (Aliph. CH), 1805
(C=O), 1252 (P=O), 1030 (P-O).
(N-benzyloxy)-3-(diethoxyphosphi -
noyl)propanamide (14)
A solution of 4.1 g (0.26mol) benzyl -
oxyamine hydrochloride and 5.8 g (0.57
mol) dry triethyl amine in 40 mL of dry
chloroform was added dropwise over two
hours to crude 13. During the addition
the reaction mixture was cooled on ice.
After the addition was completed the re -
action mixture was stirred for one hour at
room temperature. The mixture was
washed two times with 100 mL of 0.5 M
hydrochloric acid and two times with 100
mL of a solution of a 10% solution of so -
dium carbonate in water and finally two
times with brine. The last four water lay -
ers were combined and extracted once
with 100 mL of ethyl acetate. The com -
bined organic layers were concentrated
and the residue was dried by repeated ad -
dition and evaporation of a 1:1 mixture
of ethanol and toluene. The residue was
dissolved in ethyl acetate and this solu -
tion was dried with sodium sulphate
overnight. After filtration and concentra -
tion 7.1 g crude product was obtained
which was purified by chromatography
on silicagel, eluting with ethylacetate :
methanol = 20 : 1. In this way 5.5 g (69%
based on 3-(diethoxyphosphinoyl)pro -
pionic acid) 14 was obtained as an oil. 
1H NMR (60 MHz, CDCl 3) d 1.31 (t,
3H, J  = 7 Hz, CH3CH2O) 1.4-2.85 (m,
4H, CH2CH2), 4.05 (m, 4H, CH 3CH2O),
4.9 (s, 2H, OCH2Ar), 7.4 (s, 5H, C 6H5),
10.6 (s, 1H, NH); 13C NMR (200 MHz,
CDCl3), 16.1 (CH3CH2O, J CP = 5.8 Hz),
20.5 (PCH2, J CP = 143.9 Hz), 25.7
(CH2C(O)), 61.7 (CH2OP, J CP = 6.9
Hz), 77.7 (OCH2Ar), 128.13, 128.7 (Ar
CH), 135.4 (Ar C), 168.6 (C=O, J CP =
16.1 Hz); 31P NMR 30.6. IR (NaCl
plates) 3200 (NH), 3070, 3040 (Ar, CH),
2980-2880 (Aliph. CH), 1685 (C=O),






The phosphonate group was deprotected
according to the method of McKenna e t
a l .20  In an nitrogen atmosphere, 2.1 g
(13.6 mmol) bromotrimethylsilane was
added dropwise to 1.4 g (4.54 mmol) of
14. This mixture was stirred for two
hours at room temperature. Then the ex -
cess bromotrimethylsilane and the
formed ethyl bromide were removed by
rotary evaporation at deminished pres -
sure. The remaining bromotrimethylsi -
lane was removed at high vacuum (0.01
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mmHg) for half an hour. The 1H NMR
indicated that the phosphonate ethyl es -
ters had been replaced by trimethylsilyl
esters. 1H NMR (60 MHz, CDCl 3): d
0.35 (s, 18H, OSi(C H3)3), 1.5-2.9 (m,
4H, CH2CH2), 5.0 (s, 2H, OCH2Ph),
7.42 (s, 5H, C6H5); IR (NaCl plates),:
3190 (NH), 3060 (Ar. CH), 2980-2880
(Aliph. CH), 1695 (C=O), 1250 (P=O).
To the resulting syrup a solution of 0.6 g
(13.6 mmol) ethanol and 1.4 g (13.6
mmol) cyclohexylamine in diethyl ether
was added. This mixture was stirred
overnight. The resulting precipitate was
filtered over a glassfilter with suction.
The residue was recrystallised by dis -
solving it in a mixture of water and
methanol and saturating the solution with
ethanol. In this way 1.2 g dry crystalline
15 was obtained (Yield 57.4%).
Mp: 198.4°-199.7°C; 1H NMR* (200
MHz, CD3OD) d 1.92-2.17 (m, 2H,
CH2C(O)), 2.40-2.48 (m, 1H, PC H2),
2.57-2.67 (m, 1H, PC H2, J PH = 40 Hz),
4.89 (s, 1H, OCH2Ph) 5.13 (s, 1H,
OCH2Ph), 6.75 (broad s, NH,OHs), 7.34-
7.46 (m, Ph); 13C NMR** 23.5, 23.8
(PCH2, J CP = 140 Hz), 27.3, 28.6
(CH2C(O)), 78.0, 78.9 (Ph CH2O), 129.3,
129.5, 129.6, 130.1, 130.3 (Arom. CH),
134.1, 136.4 (Arom. C), 174.4, 171.3
(C=O, J CP = 16 Hz); 
31P NMR 31.1,
31.5 (2:3); IR (KBr, cm -1) b i s -cyclohex-
ylammonium salt: 3140 (NH), 3300-
2200, 2160 (NH3
+), 1640 (C=O), 1115,
1010 (P-O); MS (electrospray, H 2O/
MeOH, neg. ions): (M-1): m/e = 258,
(2M-1): m/e = 517.
(N-hydroxy)-3-phosphonopropanami -
de, bis cyclohexylammonium salt (16,
3PPH)
1.2 g (2.6 mmol) 15 was dissolved in 40
mL of a mixture of water and methanol
(1:1 v/v) and 0.4 g of 10% palladium on
carbon was added. Then this mixture was
hydrogenated at 2.5 atm. hydrogen pres -
sure overnight. The catalyst was removed
by filtration and the filtrate was concen -
trated with rotary evaporation. The re -
maining water was largely removed by
repeated addition and evaporation of a
mixture of ethanol and toluene. The resi -
due was dissolved in a little water and the
pH was adjusted to about 9 with cylo -
hexylamine. Then the solution was satu -
rated with acetone. In this way 0.9 g
(=54%) crystalline 16 was obtained.
Mp: 164.4°-166.1°C (dec.); 1H NMR***
(200 MHz, CD3OD): d 2.03 (m, 2 H,
CH2C(O), 2.44, (m, 1H, PC H2) 2.64 (m,
1H, PCH2, J PH = 40 Hz);13C NMR****(numbering in figure 3. 8)
d 25.8 (PCH2, J CP = 131 Hz), 29.4
(CH2C(O)), 174.5 (C=O, J CP = 17 Hz),
25.0 (C3),25.5 (C4), 31.6 ((C2), 51.3
(C1); 
31P NMR 97.4 (31.2 in the free
acid); IR (KBr, cm -1) 3400-2200 (NH,
OHs), 2940, 2860 (Aliph. CH), 1630
(C=O), 1550 (NH), 1030 (P-O); 
MS (electrospray, H 2O/MeOH, neg.
ions): (M-1): m/e = 168, (2M-1): m/e=
337; Anal. calc. for C 15H34N3O5P: C,
49.05, H, 9.26, N, 11.44, P, 8.45. Found:
C, 48.09, H, 9.31, N, 11.10, P, 8.43.
Ethyl 4-(diethoxyphosphinoyl)butano -
ate (17)
In a distillation apparatus with a Claisen
distillation head with a vigreux 25.4 g
(0.15 mol) of triethyl phosphite and 14.9
g (0.08 mol) of ethyl 4-bromobutyrate
were mixed. This mixture was heated for
ten hours on an oil bath of 160°C. The
ethyl bromide formed during the reaction
was distilled off (bp: 39°C). The excess
of triethyl phosphite was distilled off at
reduced pressure (55°C, p=15 mmHg).
The residue was finally distilled at high
vacuum (bp: 108°C, p=0.01 mmHg;
Figure 3.8
Numbering scheme of the bis-
cyclohexylammonium salt of
3PPH.
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* 1H , 13C and 31 P NMR spectral data were taken from the free acid.
** The 13C and 31P signals are double, probably due to the presence of two conformations of
the compound
*** 1H NMR spectral data were taken from the free acid.
**** 13C NMR and 31P NMR spectra were taken from the b i s -cyclohexylammonium salt
Lit:34 120-122°C, p=0.01 mmHg). Yield
17.8 g (90 %). 1H NMR (60 MHz,
CDCL3): d 1.20 (t, CH3CH2OC(O), J  =
5), 1.30 (t, CH3CH2OP, J  = 7 Hz), 1.5-
2.3 (m, PCH2CH2), 2.42 (t, CH2C(O), J
= 6 Hz) (triplets and multiplet together
account for 15 protons), 4.1 (m, 6H,
CH3CH2OP, CH3CH2OC(O)); IR (NaCl
plates): 2990, 2960, 2880 (Aliph. CH),




18 was prepared by dissolving 10 g (40
mmol) of 17 in 50 mL of a solution of
1.8 g of sodium hydroxide in a mixture
of water and methanol (water/methanol =
1:1). The mixture was stirred for 2 hrs. at
roomtemperature. Then it was extracted
two times with ethylacetate. The water
layer was acidified to pH 1.5 and again
extracted three times with ethylacetate.
The combined organic layers were dried
over Na2SO4. After filtration and con -
centration 8.6 g (= 96%) 18 is obtained.
1H NMR spectra were consistent with
those previously reported. IR (NaCl
plates): 3200-2350 (COOH), 2980, 2940




19 was prepared from 2.4 g (10.7 mmol)
of 18 by the dropwise addition of 2.7 g
(21.4 mmol) of oxalyl chloride over 30
minutes with cooling on ice. The mixture
was stirred for an additional 90 minutes
at roomtemperature and then the excess
of oxalyl chloride was removed by rotary
evaporation at 30°C for 30 minutes. The
residue was used in the next step without
further purification. 21 IR (NaCl plates):
3000, 2940, 2900, 2880 (Aliph. CH),




1.9 g (11.8 mmol) benzylyoxyamine hy -
drochloride 1 was converted to the free
benzylyoxyamine by the addition of 10
mL of a 4 M sodium hydroxide solution
in water and four time extraction with 25
mL of toluene. The combined organic
layers were dried on sodium sulphate and
concentrated with rotary evaporation at
diminished pressure. The residue was
dissolved in 25 mL of chloroform to
which 1.2 g (11.8 mmol) triethyl amine
was added. This solution was added
dropwise to 2.6 g (10.7 mmol) of acid
chloride 19 over half an hour. During the
addition the reaction mixture was cooled
on ice. The mixture was stirred overnigth
at room temperature and then extracted
three times with 25 mL 0.5 M hydrochlo -
ric acid then three times with 50 mL 10%
sodium carbonate. The organic layer was
dried with sodium sulphate and concen -
trated. After drying and concentration 3.1
g crude product was obtained which was
purified by chromatography over silica,
eluting with ethylacetate/ MeOH= 20:1.
Yield = 1.3 g (35,5%).
1H NMR (200 MHZ, CDCl 3): d 1.25 (t,
6H, CH3CH2OP), J  = 7.2 Hz), 1.58-1.92
(m, 4H, PCH2CH2), 2.15 (t, 2H,
CH2C(O), J  = 6.5 Hz), 3.98 (m, 4H,
CHOP, J  = 7.2 Hz), 4.83 (s, OC H2Ph),
7.26-7.32 (m, 5H, Ph), 10 (b.s., 1H, NH);
13C NMR (CDCl3): 16.4 (CH3CH2OP,
J CP = 6.4 Hz), 18.5 (PCH 2CH2), 24.2
(PCH2, J CP = 142 Hz), 32.8 (CH2C(O),
J CP = 14.4 Hz), 61.6 ( CH2OP, J CP = 6.4
Hz), 77.9 (CH2Ph), 128.4, 129.0 (Ar.
CH), 135.5 (Ar. C), 169.9 ( C=O); 
31P NMR (CDCl3) 31.2; IR (NaCl plates,
cm-1): 3183 (NH), 3064, 3029 (Arom.
CH), 2983, 2910, 2877 (Aliph. CH),
1668 (C=O), 1223 (P=O), 1053, 1028 (P-
O), 964; MS (CI, NH 3): (M+1): 
m/e
=330.
B io i s o s t e r e s  o f  2 P G H
P o s s i b l e  N e w  l e a d s  f o r  T I M  I n h i b i t o r s
E x p e r i m e n t a l  s e c t i o n      65
(N-benzyloxy)-4-phoshonobutanami -
de cyclohexylammonium salt (21)
1.3 g (3.8 mmol) of 20 was cooled on ice
in an nitrogen atmosphere. 1.7 g (11.4
mmol) bromotrimethylsilane was added
dropwise. After the addition the mixture
was stirred at room temperature for 1.5
hour. After 1.5 hour NMR indicated that
no 13 was left and the excess bro -
motrimethylsilane and the formed ethyl -
bromide was removed by rotatry
evaporation at diminished pressure. To
the residue 0.5 g (10.9 mmol) ethanol
and 1.0 g (10 mmol) cyclohexylamine in
10 mL diethyl ether was added. A white
precipitate was formed. The mixture was
stirred overnight. The precipitate was fil -
tered over a glassfilter with suction and
recrystallised from water and acetone.
Yield = 1.4 g (79%).
Mp: 188.7°-189.7°C; 1H NMR (200
MHz, CD3OD): 1.14-2.0 (m, 14H, PC H2
CH2, C(2)H2 C(3)H2 C(4)H2), 2.17 (t,
2H, CH2C(O), J  = 7.3 Hz), 3.03 (m, 1H,
CHNH3
+), 4.84 (s, 2H, OCH2Ph), 7.32-
7.45 (m, 5H, C6H5); 
13C NMR
(CD3OD): 21.4 (PCH2CH2, J CP = 3.2
Hz), 25.05 (C3), 25.6 (C4), 28.9 (PCH2,
J CP = 133.8 Hz), 31.7 ( C2), 34.6
(CH2C(O), J CP = 14.4 Hz), 51.0 ( C1),
78.7 (OCH2Ph), 129.1, 129.3, 130 (Ar.
CH), 136.7 (Ar. C), 172.4 ( C=O); 31P
NMR (CD3OD) : 26.8; IR (KBr, cm
-1):
3097 (NH), 2939, 2862 (Aliph. CH),
1655 (C=O), 1140 CH 2O), 1076, 1051
(P-O), 912; MS (electrospray,
H2O/MeOH, neg. ions): (M-1): 
m/e=272,




1 g (2.1 mmol) of 21 was dissolved in 25
mL of methanol and transferred to a Parr
flask. 150 mg of 10% Pd/C was added
the mixture was hydrogenated overnight,
at 2.5 atm. hydrogen pressure. The cata -
lyst was filtered off over celite and the
mixture was concentrated with rotary
evaporation at reduced pressure. Then
the residue was dissolved in a little water.
The pH was adjusted to about 9 with cy -
clohexylamine and acetone was added to
precipitate the product. The precipitate
was dissolved again by heating and the
mixture was set aside for crystallisation
overnight. The crystals were collected on
a glassfilter with suction. Yield of 4PBH:
0.6 g (69%). 
mp: 174.7°-175.3°C; 1H NMR* (200
MHz, D2O): 1.16-1.47 (m, 12H), 16.3-
1.68 (m, 2H), 1.81 (m, 6H), 2.00 (m,
4H), 2.23 (t, 2H, C H2C(O)), 3.15 (m,
2H, C1H) ; 
13C NMR (D2O): 20.6
(PCH2CH2, J CP = 3.5 Hz), 23.7 (C3),
24.2 (C4), 28.3 (PCH2, J CP = 130 Hz),
30.3 (C2), 33.8 (CH2C(O), J CP = 17 Hz)
50.1 (C1), 172.5 (C=O); 
31P NMR
(CD3OD/D2O) d 25.9; IR (KBr, cm
-1)
3500-2200 (NHs, OHs), 2980, 2880
(Aliph. CH), 1630 (C=O), 1550 (NH),
1050, 1020(P-O), 970; MS (electrospray,
H2O/MeOH, neg. ions): (M-1): 
m/e =182,
(2M-1): m/e =365, (3M-1): m/e =548.
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